We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,055 results
  1. Limited HIV-associated neuropathologies and lack of immune activation in sub-saharan African individuals with late-stage subtype C HIV-1 infection

    Although previous studies have suggested that subtype B HIV-1 proviruses in the brain are associated with physiological changes and immune activation...

    Zhou Liu, Peter Julius, ... Charles Wood in Journal of NeuroVirology
    Article 28 June 2024
  2. Cerebrospinal fluid CD14++CD16+ monocytes in HIV-1 subtype C compared with subtype B

    CD14 ++ CD16 + monocytes are susceptible to HIV-1 infection, and cross the blood–brain barrier. HIV-1 subtype C (HIV-1C) shows reduced Tat protein...

    Sergio M. de Almeida, Miriam Perlingeiro Beltrame, ... Ronald J. Ellis in Journal of NeuroVirology
    Article 23 May 2023
  3. Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C

    Introduction

    HIV reservoir quantification is essential for evaluation of HIV curative strategies and may provide valuable insights about reservoir...

    N. V. E. J. Buchholtz, M. M. Nühn, ... M. Nijhuis in Virology Journal
    Article Open access 31 January 2024
  4. Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG

    The magnitude of the HIV-1 epidemic in Nigeria is second only to the subtype C epidemic in South Africa, yet the subtypes prevalent in Nigeria...

    Lindsay Wieczorek, David Chang, ... Sandhya Vasan in Virology Journal
    Article Open access 29 June 2024
  5. Impact of subtype C-specific amino acid variants on HIV-1 Tat-TAR interaction: insights from molecular modelling and dynamics

    Background

    HIV-1 produces Tat, a crucial protein for transcription, viral replication, and CNS neurotoxicity. Tat interacts with TAR, enhancing HIV...

    Piwai T. Gotora, Keaghan Brown, ... Monray E. Williams in Virology Journal
    Article Open access 25 June 2024
  6. HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity

    Background

    Nef performs multiple cellular activities that enhance HIV-1 pathogenesis. The role of Nef-mediated down-regulation of the host restriction...

    Delon Naicker, Nelson Sonela, ... Jaclyn K. Mann in Retrovirology
    Article Open access 31 March 2023
  7. HIV-1 subtype B Tat enhances NOTCH3 signaling in astrocytes to mediate oxidative stress, inflammatory response, and neuronal apoptosis

    NOTCH receptors are relevant to multiple neurodegenerative diseases. However, the roles and mechanisms of NOTCH receptors in HIV-associated...

    Lin Gao, Weixi Sun, ... Hongbin Liu in Journal of NeuroVirology
    Article 26 June 2023
  8. Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology

    Whether the human brain is a robust reservoir for HIV-1 subtype C has yet to be established. We aimed to determine whether HIV-1 subtype C infection...

    Jane Musumali, Peter Julius, ... Charles Wood in Journal of NeuroVirology
    Article 05 October 2022
  9. HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment

    Variation and differential selection pressures on Tat genes have been shown to alter the biological function of the protein, resulting in...

    Vurayai Ruhanya, Graeme Brendon Jacobs, ... Susan Engelbrecht in Journal of NeuroVirology
    Article 08 April 2022
  10. Construction and Characterization of HIV-1 env-Pseudoviruses of the Recombinant Form CRF63_02A and Subtype A6

    HIV-1 env -pseudoviruses are a useful tool in the search for antiviral drugs (entry inhibitors) and evaluation of the efficacy of HIV-1 vaccines....

    N. B. Rudometova, N. S. Shcherbakova, ... L. I. Karpenko in Bulletin of Experimental Biology and Medicine
    Article 01 April 2022
  11. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis

    Background

    Ethiopia is among the highly HIV-affected countries, with reported 12,000 and 12,000 AIDS-related deaths and incidents as per reports from...

    Mulugeta Kiros, Sirak Biset, ... Alene Geteneh in Virology Journal
    Article Open access 25 October 2023
  12. Molecular epidemiology of the HIV-1 epidemic in Fiji

    Very little is known about the HIV-1 epidemic in Fiji, nor the wider South Pacific region more generally, yet new reported HIV-1 infections are on...

    Atlesh Sudhakar, Donald Wilson, ... Jemma L. Geoghegan in npj Viruses
    Article Open access 06 March 2024
  13. HIV-1 Vif protein sequence variations in South African people living with HIV and their influence on Vif-APOBEC3G interaction

    Purpose

    Despite extensive research, HIV-1 remains a global epidemic with variations in pathogenesis across regions and subtypes. The Viral Infectivity...

    Article Open access 11 December 2023
  14. Characterization of an imported HIV-1 A1/A7/G recombinant in China

    Background

    International migration has accelerated the HIV-1 spread across national borders, gradually reducing the restrictions on the geographical...

    Qing-Hai Li, Yun-Qi Zhang, ... Jia-Ye Wang in Virology Journal
    Article Open access 04 January 2024
  15. Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy

    Mosaic HIV-1 vaccines have been shown to elicit robust humoral and cellular immune responses in people living with HIV-1 (PLWH), that had started...

    Boris Julg, Kathryn E. Stephenson, ... Dan H. Barouch in npj Vaccines
    Article Open access 23 May 2024
  16. A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design

    Background

    Identifying immunogens which can elicit effective T cell responses against human immunodeficiency virus type 1 (HIV-1) is important for...

    Hui Zhang, Chuan He, ... Hong Shang in BMC Immunology
    Article Open access 02 April 2022
  17. A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors

    Background

    Maturation inhibitors (MIs) potently block HIV-1 maturation by inhibiting the cleavage of the capsid protein and spacer peptide 1 (CA-SP1)....

    Dibya Ghimire, Yuvraj KC, ... Ritu Gaur in Retrovirology
    Article Open access 09 April 2021
  18. Sex differences in cognitive function among people with HIV-1 clade C infection in Northern India

    Human immunodeficiency virus-1 (HIV-1) clade C is the most prevalent form of HIV-1 comprising nearly 46% of global infections and is the dominant...

    Anchal Sharma, Manju Mohanty, ... Mahendra Kumar in Journal of NeuroVirology
    Article 12 September 2023
  19. Recombinant characteristics of three novel HIV-1 second-generation recombinant forms composed of CRF01_AE and CRF07_BC isolated in Hebei province, China

    Human immunodeficiency virus 1 (HIV-1) is a fast-evolving, genetically diverse virus. The HIV-1 evolution rate is also significantly influenced by...

    **nli Lu, **nyu Zhang, ... Qi Li in Archives of Virology
    Article 14 March 2023
  20. Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda

    Background

    Our understanding of the peripheral human immunodeficiency virus type 1 (HIV-1) reservoir is strongly biased towards subtype B HIV-1...

    Samira Joussef-Piña, Immaculate Nankya, ... Miguel E. Quiñones-Mateu in Retrovirology
    Article Open access 15 January 2022
Did you find what you were looking for? Share feedback.